Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,844 papers from all fields of science
Search
Sign In
Create Free Account
nicergolin von ct
Known as:
ct Arzneimittel Brand of Nicergoline
, ct-Arzneimittel Brand of Nicergoline
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Nicergoline
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective…
A. Scholtz
,
A. Hahn
,
+6 authors
G. Weisshaar
Clinical drug investigation
2019
Corpus ID: 203609861
Vertigo derived from peripheral vestibular disorders is quite frequently encountered in daily clinical practice and can be a…
Expand
2016
2016
Entlassungsmedikation – Was weiß der Patient bei Entlassung über seine Arzneimittel?
Johanna Freyer
,
Claudia Greißing
,
+6 authors
T. Bertsche
Deutsche Medizinische Wochenschrift
2016
Corpus ID: 196468968
Zusammenfassung Hintergrund | Mangelndes Wissen des Patienten über die Entlassungsmedikation kann die Patientensicherheit gef…
Expand
2014
2014
Competing time-to-event endpoints in cardiology trials: A simulation study to illustrate the importance of an adequate statistical analysis
G. Rauch
,
M. Kieser
,
+5 authors
J. Senges
European Journal of Preventive Cardiology
2014
Corpus ID: 10482289
Background: Clinical trials in cardiology commonly consider time-to-event endpoints that are often influenced by competing risks…
Expand
2010
2010
Einführung neuer Arzneimittel in europäische Gesundheitssysteme
Björn Wettermark
,
Brian Godman
,
+6 authors
Lars Gustafsson
2010
Corpus ID: 112723497
Die Ausgaben fur Arzneimittel sind in Europa in den vergangenen Jahrzehnten stark gestiegen. Grund dafur sind in erster Linie…
Expand
Review
2009
Review
2009
St. John’s Wort – an Overview
K. Linde
Complementary Medicine Research
2009
Corpus ID: 1975915
This article aims to summarize the current state of knowledge on St. John’s wort (Hypericum perforatum L.) which is one of the…
Expand
Review
2009
Review
2009
Environmental risk assessment for medicinal products containing genetically modified organisms
Brigitte Anliker
,
S. Longhurst
,
Christian J. Buchholz
Bundesgesundheitsblatt - Gesundheitsforschung…
2009
Corpus ID: 19669913
Many gene therapy medicinal products and also some vaccines consist of, or contain, genetically modified organisms (GMOs), which…
Expand
2006
2006
Das anti-inflammatorische Potential von Padma 28 – Übersicht experimenteller Daten zur antiatherogenen Wirkung und Diskussion des Vielstoffkonzepts
Florian Ueberall
,
D. Fuchs
,
C. Vennos
Complementary Medicine Research
2006
Corpus ID: 71569372
Hintergrund: Das Tibetische Arzneimittel Padma 28 wird seit Jahrzehnten in Europa angewendet und hat sich besonders bei entz…
Expand
Review
2004
Review
2004
Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: A systematic analysis of evidence for the herbal preparation Iberogast®
G. Holtmann
,
B. Adam
,
B. Vinson
Wiener Medizinische Wochenschrift
2004
Corpus ID: 28109835
SummaryFunctional gastrointestinal disorders like functional dyspepsia and irritable bowel syndrome are characterized by more or…
Expand
1996
1996
A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity againstShiga-like toxins and EHEC-hemolysin ofEscherichia coli O157:H7
R. Lissner
,
H. Schmidt
,
H. Karch
Infection
1996
Corpus ID: 31943619
SummaryEnterohemorrhagicEscherichia coli (EHEC) causes a variety of clinical conditions, the most important being hemorrhagic…
Expand
1958
1958
Experimentelle Untersuchungen an Ratten über die Metastasierung von Tumoren
D. Schmähl
,
Thomas Rieseberg
Zeitschrift für Krebsforschung
1958
Corpus ID: 41801848
1. An einem Tiermaterial von über 500 Ratten wurden experimentelle Untersuchungen über die Metastasierung von Tumoren durchgef…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE